Human antibodies to respiratory syncytial virus F protein and methods of use thereof
US9447173B2 · kind B2 · utility
10Cited by
9References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2014 |
| Grant date | Sep 20, 2016 |
| Priority date | — |
| Expiry date | Mar 13, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/135
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides fully human antibodies that bind to respiratory syncytial virus F protein, compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for preventing fusion of the virus with the cell membrane and preventing cell to cell spread of the virus, thereby providing a means of preventing the infection, or treating a patient suffering from the infection and ameliorating one or more symptoms or complications associated with the viral infection. The antibodies may also be useful for diagnosis of an infection by RSV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.